Pain Alleviation of Forearm Fractures
关键词
抽象
描述
Fractures of the forearm are extremely common, Pain relief is of utmost importance in forearm fractures which may need manipulation immediately for reduction followed by operative intervention
The characteristic features of ideal analgesia during reduction are determined by safety, simplicity, affectivity and costs. Giventhe logistic difficulty of providing such anesthesia to such large number of patients simpler alternatives to conventional anesthesia have been tried. Hematoma Block alone, Hematoma Block with sedation, Bier's Block (Intravenous regional anesthesia), regional nerve blocks, sedation have been compared to general anesthesia to evaluate the efficacy, effectiveness, safety in treating such patients
Amongst various techniques, HB and IVRA are attractive options. However, while HB has been demonstrated to be safe simple and has been used effectively for treatment of radius fractures in ER and for immediate pain relief it doesn't provide muscular relaxation and may not be sufficient for any operative intervention
IVRA is suitable for operations of the distal extremities, in situations where it is safe and easy to apply an occlusive tourniquet. The primary advantages of IVRA are its simplicity, reliability, and cost-effectiveness. . It is a regional anesthetic technique that is easy to perform, with success rates varying between 94% and 98%.For these reasons, it remains a popular choice among anesthesiologists.
A combination of blocks is usually done to overcome the deficiencies of individual blocks and to improve operating conditions or to prolong post operative analgesia. However the use of dual technique of IVRA and HB with local anesthetic only offered near absence of post operative analgesia
Lidocaine is the most frequently used LA for IVRA and HB
Different agents have been used as additive to local anesthetic for IVRA including phencyclidines, non-steroidal anti inflammatory drugs, opioids, and muscle relaxants. Ketamine is an effective anesthetic agent for IVRA at concentrations between 0.3% and 0.5%.it improves quality of anesthesia and peri operative analgesia without causing side effects
Ketamine, a phenyl-piper dine derivative, was first synthesized in the early 1960 as an IV anesthetic agent. At sub anesthetic doses, ketamine exerts a noncompetitive blockade of N -methyl aspartate (NMDA) receptors. NMDA receptors play a major role in synaptic plasticity and are specifically implicated in central nervous system facilitation of pain processing. NMDA receptor antagonists have been implicated in perioperative pain management. Ketamine also has local anesthetic qualities, which have been studied as a sole agent for IVRA. In addition to spinal cord NMDA receptors, NMDA receptors have also been identified on peripheral unmyelinated sensory axons. This can explain why ketamine as an NMDA receptor antagonist was able to attenuate the tourniquet pain.
日期
最后验证: | 01/31/2019 |
首次提交: | 12/11/2017 |
提交的预估入学人数: | 12/15/2017 |
首次发布: | 12/18/2017 |
上次提交的更新: | 02/25/2019 |
最近更新发布: | 02/27/2019 |
实际学习开始日期: | 01/31/2018 |
预计主要完成日期: | 10/31/2018 |
预计完成日期: | 11/30/2018 |
状况或疾病
干预/治疗
Drug: Ketamine in hematoma block
Drug: ketamine intravenous anesthesia
Drug: lidocaine intravenous anesthesia
相
手臂组
臂 | 干预/治疗 |
---|---|
Active Comparator: Ketamine in hematoma block Ketamine used in hematoma block | Drug: Ketamine in hematoma block ketamine used in local hematoma block only |
Active Comparator: ketamine intravenous anesthesia ketamine used in local intravenous anesthesia | Drug: ketamine intravenous anesthesia ketamine will be used with lidocaine in local intravenous anesthesia |
Active Comparator: lidocaine intravenous anesthesia 2.5 mg/kg of lidocaine 2% diluted with saline to a total volume of 40 ml. | Drug: lidocaine intravenous anesthesia 2.5 mg/kg of lidocaine 2% in intravenous regional anesthesia |
资格标准
有资格学习的年龄 | 18 Years 至 18 Years |
有资格学习的性别 | All |
接受健康志愿者 | 是 |
标准 | Inclusion Criteria: - All patients aged more than 18 years old. - American Society of Anesthesiologists (ASA) physical status I or II. - Patients scheduled for closed fracture of distal upper extremity within 7 days, requiring open or closed reduction and internal fixation. - Patients scheduled for procedure lasting less than 90 minutes. Exclusion Criteria: - Patients having cardiovascular co-morbidities. - Compound or contaminated fracture. - Peripheral vascular disease, sickle cell disease or coagulation disorders. - Allergy to the local anesthetics or to the drugs used in the study. |
结果
主要结果指标
1. pain assessment [24 hours]
次要成果指标
1. analgesia requirement [24 hours]